AVDL

Avadel Pharmaceuticals

71 hedge funds and large institutions have $332M invested in Avadel Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 21 increasing their positions, 25 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

3% less capital invested

Capital invested by funds: $342M → $332M (-$10.3M)

16% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 25

Holders
71
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.45M
Puts
$611K
Net Calls
Net Calls Change

Top Buyers

1 +$6.61M
2 +$5.72M
3 +$4.4M
4
TI
Turner Investments
Pennsylvania
+$2.7M
5
Morgan Stanley
Morgan Stanley
New York
+$2.18M

Top Sellers

1 -$9.45M
2 -$3.75M
3 -$2.72M
4
Millennium Management
Millennium Management
New York
-$2.2M
5
Jennison Associates
Jennison Associates
New York
-$1.54M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$1.73M
27
$1.64M
28
$1.6M
29
$930K
30
$905K
31
$887K
32
$834K
33
$780K
34
$775K
35
$749K
36
$708K
37
$656K
38
$594K
39
$497K
40
$446K
41
$444K
42
$373K
43
$372K
44
$333K
45
$301K
46
$255K
47
$218K
48
$197K
49
$179K
50
$156K